scholarly journals DENTATE GYRUS MOLECULAR LAYER MICROGLIA CHANGES, IL1-β AND BEHAVIOR IN MOUSE VALPROIC ACID MODEL OF AUTISM SPECTRUM DISORDERS

Author(s):  
Alinne Lorrany Gomes Dos Santos ◽  
Ellen Rose Leandro Ponce de Leão ◽  
Larissa Victória Barra de Moura ◽  
Dilza Souza ◽  
Daniel Guerreiro Diniz ◽  
...  
Author(s):  
Alinne Lorrany Gomes Dos Santos ◽  
Luma Cristina Guerreiro Ferreira ◽  
Dilza Souza ◽  
Daniel Guerreiro Diniz ◽  
Cristovam Wanderley Picanço Diniz

Author(s):  
Jill Escher ◽  
Wei Yan ◽  
Emilie F. Rissman ◽  
Hsiao-Lin V. Wang ◽  
Arturo Hernandez ◽  
...  

AbstractInvestigations into the etiology of autism spectrum disorders have been largely confined to two realms: variations in DNA sequence and somatic developmental exposures. Here we suggest a third route—disruption of the germline epigenome induced by exogenous toxicants during a parent’s gamete development. Similar to cases of germline mutation, these molecular perturbations may produce dysregulated transcription of brain-related genes during fetal and early development, resulting in abnormal neurobehavioral phenotypes in offspring. Many types of exposures may have these impacts, and here we discuss examples of anesthetic gases, tobacco components, synthetic steroids, and valproic acid. Alterations in parental germline could help explain some unsolved phenomena of autism, including increased prevalence, missing heritability, skewed sex ratio, and heterogeneity of neurobiology and behavior.


2009 ◽  
pp. n/a-n/a ◽  
Author(s):  
Benjamin E. Yerys ◽  
Gregory L. Wallace ◽  
Jennifer L. Sokoloff ◽  
Devon A. Shook ◽  
Joette D. James ◽  
...  

Author(s):  
C. Sue Carter ◽  
Suma Jacob

The effects of oxytocin and vasopressin on the brain and behavior can be sexually dimorphic, especially during the course of development (Bales, Kim, et al., 2004; Bales, Pfeifer, et al., 2004; Bales, Plotsky, et al., 2007; Bielsky et al., 2005a; Carter, 2003; Thompson et al., 2006; Yamamoto et al., 2005; Yamamoto et al., 2004). Given the sexual discrepancy observed in autism spectrum disorders (ASDs), these two neuropeptides, oxytocin (OT) and arginine vasopressin (AVP), have received attention for their potential role in ASDs (Green and Hollander, 2010; Insel et al., 1999; Leckman & Herman, 2002; Welch et al., 2005; Winslow, 2005; Young et al., 2002). Changes in either OT or AVP and their receptors could be capable of influencing symptom domains or behaviors associated with ASDs. Arginine vasopressin is androgen dependent in some brain regions (De Vries & Panzica, 2006), and males are more sensitive to AVP, especially during development. We hypothesize here that AVP, which has a unique role in males, must be present in optimal levels to be protective against ASDs. Either excess AVP or disruptions in the AVP system could play a role in development of the traits found in ASDs. In contrast, OT may possibly be secreted in response to adversity, especially in females, serving as a protective factor.


2021 ◽  
Author(s):  
Yvonne M.Y. Han ◽  
Suk Yu Yau ◽  
Melody M.Y. Chan ◽  
Chun Kwok Wong ◽  
Agnes S. Chan

Abstract Previous studies have shown that immunological factors are involved in the pathogenesis of autism spectrum disorders (ASDs). The present study examined whether immunological abnormalities are associated with cognitive deficits and problem behaviors in children with ASD and whether children with ASD show different immunological biomarkers and brain-derived neurotrophic factor BDNF levels than typically developing (TD) children. Sixteen TD and 18 children with ASD, aged 6–18 years, voluntarily participated in the study. Participants’ executive functions were measured using neuropsychological tests, and behavioral measures were measured using parent ratings. Immunological measures were assessed by measuring the levels of chemokine ligand 2 (CCL2) and chemokine ligand 5 (CCL5) in participants’ blood serum. Children with ASD showed greater deficits in cognitive functions as well as altered levels of immunological measures when compared to TD children, and their cognitive functions and behavior deficits were significantly associated with increased CCL5 levels and decreased BDNF levels. These results provide evidence to support the notion that altered immune functions are associated with neuronal deficits, are indexed by decreased levels of BDNF and manifest as selective cognitive and behavioral symptoms in individuals with ASD.


2014 ◽  
Vol 18 (4) ◽  
pp. 177-185 ◽  
Author(s):  
Fernando Navarro ◽  
Deborah A Pearson ◽  
Nicole Fatheree ◽  
Rosleen Mansour ◽  
S Shahrukh Hashmi ◽  
...  

2020 ◽  
Vol 21 (10) ◽  
pp. 3576 ◽  
Author(s):  
Magdalena Gąssowska-Dobrowolska ◽  
Magdalena Cieślik ◽  
Grzegorz Arkadiusz Czapski ◽  
Henryk Jęśko ◽  
Małgorzata Frontczak-Baniewicz ◽  
...  

Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental conditions categorized as synaptopathies. Environmental risk factors contribute to ASD aetiology. In particular, prenatal exposure to the anti-epileptic drug valproic acid (VPA) may increase the risk of autism. In the present study, we investigated the effect of prenatal exposure to VPA on the synaptic morphology and expression of key synaptic proteins in the hippocampus and cerebral cortex of young-adult male offspring. To characterize the VPA-induced autism model, behavioural outcomes, microglia-related neuroinflammation, and oxidative stress were analysed. Our data showed that prenatal exposure to VPA impaired communication in neonatal rats, reduced their exploratory activity, and led to anxiety-like and repetitive behaviours in the young-adult animals. VPA-induced pathological alterations in the ultrastructures of synapses accompanied by deregulation of key pre- and postsynaptic structural and functional proteins. Moreover, VPA exposure altered the redox status and expression of proinflammatory genes in a brain region-specific manner. The disruption of synaptic structure and plasticity may be the primary insult responsible for autism-related behaviour in the offspring. The vulnerability of specific synaptic proteins to the epigenetic effects of VPA may highlight the potential mechanisms by which prenatal VPA exposure generates behavioural changes.


2020 ◽  
Vol 9 (1S) ◽  
Author(s):  
Dinda Puan Rizka Wiranti ◽  
Amel Yanis ◽  
Deddy Saputra Saputra

Pengobatan untuk Autism Spectrum Disorders (ASD) belum ditemukan saat ini. Paparan Valproic Acid (VPA) pada ibu hamil merupakan faktor lingkungan terjadinya ASD pada anak. Patomekanisme diduga adanya gangguan sinaps. Mayoritas orang tua anak ASD mengalami peningkatan stres kronis yang dapat berdampak pada kesehatan fisik dan emosional karena menyebabkan beban sosial dan finansial. Penelitian sebelumnya menemukan aktivitas neuronal bisa distimulasi melalui pengayaan lingkungan. Tujuan: Mengetahui pengaruh pengayaan lingkungan terhadap gejala Autistic Like Behavior (ALB); penurunan interaksi sosial dan peningkatan gerakan repetitif. Metode: Penelitian ini merupakan studi eksperimental laboratorik dengan one group pretest post test without control. Sampel terdiri dari 6 ekor tikus Spraque Dawley (SD) yang diinjeksikan dengan VPA 500 mg/kgBB intraperitoneal yang dilarutkan dalam normal saline menjadi 1.5 ml, kemudian diambil enam ekor anak tikus usia tiga minggu yang mempunyai gejala ALB dan dipindahkan ke kandang pengayaan lingkungan selama empat minggu. Pengamatan dilakukan menggunakan Closed Circuit Television (CCTV). Analisis data menggunakan uji t-berpasangan. Hasil: Analisis data didapatkan hasil uji t-berpasangan pada perilaku interaksi sosial dan gerakan repetitif adalah p=0.001 dan p= 0.003. Simpulan: Ada perbedaan yang signifikan perilaku interaksi sosial dan gerakan repetitif hewan coba sebelum dan sesudah pemberian pengayaan lingkungan selama 4 minggu.


Sign in / Sign up

Export Citation Format

Share Document